Showing results (1-10 of 114) with videos related to
Sort By:
Pageof 12
Essays in Biochemistry|July 30, 2026
Chemogenomic sets: valuable tools for early-stage drug discoveryMaura Q Schoppa, David H DrewryCurrent Opinion in Chemical Biology|April 24, 2010
Enhancements of screening collections to address areas of unmet medical need: an industry perspectiveDavid H Drewry, Ricardo MacarronMethods in Molecular Biology (Clifton, N.J.)|August 9, 2023
Developing a Kinase Chemogenomic Set: Facilitating Investigation into Kinase Biology by Linking Phenotypes to TargetsCarrow I Wells, David H DrewryKinases and Phosphatases|August 6, 2026
CK2 Chemical Probes: Past, Present, and FutureHan Wee Ong, David H Drewry, Alison D AxtmanCurrent Topics in Medicinal Chemistry|November 29, 2013
Seeding collaborations to advance kinase science with the GSK Published Kinase Inhibitor Set (PKIS)David H Drewry, Timothy M Willson, William J ZuercherJournal of Chemical Information and Modeling|December 5, 2008
Kinase-targeted library design through the application of the PharmPrint methodologyFelix Deanda, Eugene L Stewart, Michael J Reno, et al.Combinatorial Chemistry & High Throughput Screening|April 23, 2002
Optimization of focused chemical libraries using recursive partitioningAndrew Rusinko, S Stanley Young, David H Drewry, et al.Tetrahedron Letters|October 5, 2020
Concise, gram-scale synthesis of furo[2,3-b]pyridines with functional handles for chemoselective cross-couplingSean N O'Byrne, Benjamin J Eduful, Timothy M Willson, et al.Cancers|June 22, 2023
Targeting the Divergent Roles of STK3 Inhibits Breast Cancer Cell Growth and Opposes Doxorubicin-Induced Cardiotoxicity In VitroJiung Nam, Amelia U Schirmer, Chelsea Loh, et al.SLAS Discovery : Advancing Life Sciences R & D|April 30, 2019
A Perspective on Extreme Open Science: Companies Sharing Compounds without RestrictionDavid H Drewry, Carrow I Wells, William J Zuercher, et al.Pageof 12